INNATE PHARMA (EPA:IPH) | Finanzwire

Basculer en Français

8596	Companies
140137	Keywords
76060	Articles
74828	Press releases

Home
Companies
INNATE PHARMA

PRESS RELEASE

published on 03/28/2025 at 14:37, 5 days 21 hours ago

Annual financial and audit reports / Annual financial report
BRIEF

published on 03/20/2025 at 07:05, 14 days 4 hours ago

Innate Pharma Announces 2024 Financial Results Conference

Financial Results Conference Call Stock Market Listing Cancer Immunotherapy Innate Pharma
PRESS RELEASE

published on 03/20/2025 at 07:00, 14 days 4 hours ago

Inside Information / Other news releases
Innate Pharma to hold conference call and webcast for full year 2024 financial results on March 27, 2025. Details for participation provided

Financial Results Conference Call Biotechnology Webcast Innate Pharma
BRIEF

published on 02/17/2025 at 07:07, 1 month 14 days ago

Innate Pharma Receives Breakthrough Therapy Designation from FDA

FDA Innate Pharma Breakthrough Therapy Lacutamab Sézary Syndrome
PRESS RELEASE

published on 02/17/2025 at 07:02, 1 month 14 days ago

Inside Information / Other news releases
Innate Pharma receives U.S. FDA Breakthrough Therapy Designation for Lacutamab in Sézary syndrome treatment, showing promising results in Phase 2 TELLOMAK study

FDA Innate Pharma Lacutamab Sézary Syndrome Breakthrough Therapy Designation
BRIEF

published on 01/27/2025 at 07:05, 2 months 7 days ago

Innate Pharma Initiates Phase 1 Study of IPH4502 for Advanced Solid Tumors

Phase 1 Trial Innate Pharma IPH4502 Nectin-4 Advanced Solid Tumors
PRESS RELEASE

published on 01/27/2025 at 07:00, 2 months 7 days ago

Inside Information / Other news releases
Innate Pharma announces first patient dosed in Phase 1 study of Nectin-4 targeting Antibody Drug IPH4502 in advanced solid tumors. Innovative ADC for multiple cancer types

Innate Pharma Phase 1 Study IPH4502 Topoisomerase I Inhibitor Antibody Drug Conjugate
BRIEF

published on 01/16/2025 at 07:05, 2 months 18 days ago

New Share and Voting Rights Report for Innate Pharma

Common Shares Voting Rights AMF Shareholding Structure Innate Pharma
PRESS RELEASE

published on 01/16/2025 at 07:00, 2 months 18 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Innate Pharma releases shares and voting rights update as of December 31, 2024, in compliance with regulations. Learn more about the global biotech company's innovative immunotherapies for cancer patients

Voting Rights Shares Biotechnology Immunotherapy Innate Pharma
BRIEF

published on 12/20/2024 at 07:05, 3 months 14 days ago

Innate Pharma at the 43rd JP Morgan Healthcare Conference

Investors Immunotherapy Innate Pharma JP Morgan Conference Live Presentation

Accesswire

Published on 04/03/2025 at 11:00, 46 minutes ago

Focus Graphite Advanced Materials Initiates Validation Testing of Lac Knife Anode Materials with Leading Battery Innovator C4V
Published on 04/03/2025 at 05:10, 6 hours 36 minutes ago

Battery X Metals Announces Corporate Awareness Agreement
Published on 04/03/2025 at 01:35, 10 hours 11 minutes ago

GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 12 hours 11 minutes ago

Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 15 hours 46 minutes ago

Network-1 Announces Acquisition of Patent Portfolio

View all ACCESSWIRE

EQS Group

Published on 04/03/2025 at 11:15, 30 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/03/2025 at 09:00, 2 hours 45 minutes ago

Partners Group to invest in Gestcompost, the largest organic waste manager in Spain, through a continuation fund
Published on 04/03/2025 at 09:00, 2 hours 45 minutes ago

Upward trends in Europe – growing investor interest?
Published on 04/03/2025 at 08:30, 3 hours 15 minutes ago

ALVAREZ & MARSAL CREATES LEADING CORPORATE FINANCE PRACTICE IN SWITZERLAND BY JOINING FORCES WITH AVELA CAPITAL LED BY STEPHAN BRÜCHER
Published on 04/03/2025 at 08:15, 3 hours 30 minutes ago

'CGTN: China-India ties at 75: 'Dragon-Elephant Tango' will benefit both'

Les Echos

Published on 04/03/2025 at 09:45, 2 hours ago

GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 31/03/2025
Published on 04/03/2025 at 09:35, 2 hours 10 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2025
Published on 04/03/2025 at 08:45, 3 hours 1 minute ago

Baikowski: Strong growth in 2024 full-year results
Published on 04/03/2025 at 08:00, 3 hours 46 minutes ago

Availability of preparatory documents for the Annual Shareholders’ Meeting of OPmobility SE
Published on 04/03/2025 at 00:37, 11 hours 8 minutes ago

Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code

View all LES ECHOS COMFI WIRE